CALGB 30103: A randomized phase II study of carboplatin and etoposide (CE) with or without G3139 in patients with extensive stage small cell lung cancer (ES-SCLC).
- Citation:
- J Clin Oncol vol 23 (16s) abstract 7168
- Year:
- 2005
- Type:
- Abstract
- Sub type:
- Poster General
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Parents:
- None
- Children:
- 183
- Program:
- OGC
- Primary Committee:
- Respiratory
- Sec. Committees:
- Pharmas:
- Grants:
- Corr. Author:
- Authors:
- C. M. Rudin R. Salgia X. F. Wang M. R. Green E. E. Vokes
- Networks:
- Study
- CALGB-30103
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 2
- Keywords: